文献速递胸部技术与安全PETCT

利用PET/CT影像组学预测NSCLC患者PD-L1表达及对PD-L1阳性NSCLC免疫治疗患者的预后建模

Prediction of PD-L1 expression in NSCLC patients using PET/CT radiomics and prognostic modelling for immunotherapy in PD-L1-positive NSCLC patients.
PubMed 文献 · Clin Radiol · 2025-04-02

该回顾性研究分析了143例治疗前接受18F-FDG PET/CT的NSCLC患者(其中86例PD-L1阳性),构建20个模型预测PD-L1表达,基于SVM的临床联合PET/CT影像组学模型表现最佳(训练集AUC 0.914,测试集AUC 0.877)。Cox分析显示吸烟史独立预测PFS,SUVmean、单核细胞百分比和白细胞计数独立预测OS,并据此构建预测1年、2年和3年OS的列线图。

要点

  • 基于SVM的临床联合PET/CT影像组学模型预测PD-L1表达最佳,训练集AUC 0.914、测试集AUC 0.877。
  • 在PD-L1阳性接受一线免疫治疗患者中,吸烟史是PFS的独立预测因素。
  • SUVmean、单核细胞百分比和白细胞计数是OS的独立预测因素,列线图可预测1年、2年和3年OS。

核心结论

  • 研究开发了基于PET/CT的机器学习模型帮助预测NSCLC患者PD-L1表达,并识别了PD-L1阳性免疫治疗患者PFS和OS的独立预测因素,从而辅助精准治疗。

研究设计与样本

  • 回顾性分析143例NSCLC患者,均接受治疗前18F-FDG PET/CT扫描,其中86例PD-L1阳性;采用Bayes、逻辑回归、随机森林和SVM四种机器学习算法构建模型,以ROC曲线验证预测性能。

诊断标准与关键数值

  • 基于SVM算法的临床联合PET/CT影像组学模型预测PD-L1表达表现最佳,训练集AUC为0.914,测试集AUC为0.877。

临床应用与阅片要点

  • 作者认为基于PET/CT的机器学习模型可能有助于预测NSCLC患者PD-L1表达,并识别PD-L1阳性免疫治疗患者PFS和OS的独立预测因素,从而辅助精准治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To develop a positron emission tomography/computed tomography (PET/CT)-based radiomics model for predicting programmed cell death ligand 1 (PD-L1) expression in non-small cell lung cancer (NSCLC) patients and estimating progression-free survival (PFS) and overall survival (OS) in PD-L1-positive patients undergoing first-line immunotherapy.

MATERIALS AND METHODS: We retrospectively analysed 143 NSCLC patients who underwent pretreatment 18F-fluorodeoxyglucose (18F-FDG) PET/CT scans, of whom 86 were PD-L1-positive. Clinical data collected included gender, age, smoking history, Tumor-Node-Metastases (TNM) staging system, pathologic types, laboratory parameters, and PET metabolic parameters. Four machine learning algorithms-Bayes, logistic, random forest, and Supportsupport vector machine (SVM)-were used to build models. The predictive performance was validated using receiver operating characteristic (ROC) curves. Univariate and multivariate Cox analyses identified independent predictors of OS and PFS in PD-L1-positive expression patients undergoing immunotherapy, and a nomogram was created to predict OS.

RESULTS: A total of 20 models were built for predicting PD-L1 expression. The clinical combined PET/CT radiomics model based on the SVM algorithm performed best (area under curve for training and test sets: 0.914 and 0.877, respectively). The Cox analyses showed that smoking history independently predicted PFS. SUVmean, monocyte percentage and white blood cell count were independent predictors of OS, and the nomogram was created to predict 1-year, 2-year, and 3-year OS based on these three factors.

CONCLUSION: We developed PET/CT-based machine learning models to help predict PD-L1 expression in NSCLC patients and identified independent predictors of PFS and OS in PD-L1-positive patients receiving immunotherapy, thereby aiding precision treatment.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Peng M, Wang M, Yang X, et al. Prediction of PD-L1 expression in NSCLC patients using PET/CT radiomics and prognostic modelling for immunotherapy in PD-L1-positive NSCLC patients. Clin Radiol. 2025. PMID: 40375402. doi:10.1016/j.crad.2025.106915

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。